⚕️
Sağlık Hizmetleri Sektörü Hisseleri
Sağlık Hizmetleri Sektörü altında 807 Hisse Senedi
Sağlık Hizmetleri sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$76.4B
Toplam Piyasa Değeri
Sağlık Hizmetleri Sektörü Hisseleri
Sayfa 4/9 (Toplam: 807)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| USPH | U.S. Physical Therapy, Inc. | $1.12B | $73.85 | 0.12% |
| ASTH | Astrana Health, Inc. | $1.12B | $23.04 | 0.04% |
| PHAT | Phathom Pharmaceuticals, Inc. | $1.11B | $15.62 | 2.97% |
| ATNF | 180 Life Sciences Corp. | $1.08B | $7.04 | 7.49% |
| PCRX | Pacira BioSciences, Inc. | $1.07B | $23.57 | 1.01% |
| BHVN | Biohaven Ltd. | $1.06B | $10.03 | 5.80% |
| KURA | Kura Oncology, Inc. | $1.06B | $12.14 | 1.25% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.05B | $16.17 | 1.13% |
| OPK | OPKO Health, Inc. | $1.04B | $1.35 | 1.12% |
| IART | Integra LifeSciences Holdings Corporation | $1.02B | $13.12 | 0.00% |
| MDXG | MiMedx Group, Inc. | $1.02B | $6.88 | 0.00% |
| EYPT | EyePoint Pharmaceuticals, Inc. | $1.02B | $14.83 | 0.27% |
| BCAX | Bicara Therapeutics Inc. Common Stock | $1.02B | $18.56 | 2.32% |
| GLYC | GlycoMimetics, Inc. | $1.01B | $15.71 | 2.76% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $999.16M | $3.62 | 0.55% |
| VERV | Verve Therapeutics, Inc. | $994.04M | $11.13 | 0.27% |
| DAWN | Day One Biopharmaceuticals, Inc. | $974.39M | $9.49 | 0.85% |
| PNTG | The Pennant Group, Inc. | $958.25M | $27.70 | 1.39% |
| MNMD | Mind Medicine (MindMed) Inc. | $955.75M | $12.65 | 4.55% |
| GDRX | GoodRx Holdings, Inc. | $953.62M | $2.81 | 0.71% |
| PSNL | Personalis, Inc. | $952.82M | $10.73 | 0.09% |
| AVBP | ArriVent BioPharma, Inc. Common Stock | $946.95M | $22.94 | 0.48% |
| NTLA | Intellia Therapeutics, Inc. | $942.03M | $8.99 | 5.52% |
| SPRY | ARS Pharmaceuticals, Inc. | $936.76M | $9.54 | 0.31% |
| PLSE | Pulse Biosciences, Inc. | $927.74M | $13.69 | 0.73% |
| CDNA | CareDx, Inc | $919.14M | $17.87 | 0.34% |
| ARVN | Arvinas, Inc. | $913.15M | $12.57 | 1.21% |
| FLGT | Fulgent Genetics, Inc. | $907.97M | $29.58 | 1.89% |
| RZLT | Rezolute, Inc. | $901.31M | $9.72 | 1.67% |
| RIGL | Rigel Pharmaceuticals, Inc. | $901.05M | $50.49 | 0.92% |
| ERAS | Erasca, Inc. | $899.37M | $3.17 | 1.28% |
| VIR | Vir Biotechnology, Inc. | $892.41M | $6.42 | 0.39% |
| LENZ | LENZ Therapeutics, Inc. | $851.83M | $30.52 | 0.65% |
| MDRX | Veradigm Inc. | $849.15M | $5.00 | 3.09% |
| ABUS | Arbutus Biopharma Corporation | $845.61M | $4.40 | 0.23% |
| SIBN | SI-BONE, Inc. | $844.35M | $19.46 | 0.10% |
| IOVA | Iovance Biotherapeutics, Inc. | $819.27M | $2.47 | 1.23% |
| ALMS | Alumis Inc. Common Stock | $800.76M | $7.67 | 0.39% |
| CMPX | Compass Therapeutics, Inc. | $800.68M | $5.79 | 7.42% |
| ESPR | Esperion Therapeutics, Inc. | $792.10M | $4.01 | 1.52% |
| REPL | Replimune Group, Inc. | $784.40M | $10.00 | 0.60% |
| BFLY | Butterfly Network, Inc. | $783.05M | $3.10 | 0.65% |
| CRMD | CorMedix Inc. | $772.92M | $9.81 | 1.66% |
| GOSS | Gossamer Bio, Inc. | $758.40M | $3.34 | 0.00% |
| GERN | Geron Corporation | $753.26M | $1.18 | 0.84% |
| EMBC | Embecta Corp. | $746.30M | $12.76 | 1.47% |
| HSTM | HealthStream, Inc. | $746.15M | $25.15 | 0.67% |
| KALV | KalVista Pharmaceuticals, Inc. | $731.40M | $14.47 | 2.62% |
| CTMX | CytomX Therapeutics, Inc. | $724.90M | $4.28 | 1.42% |
| CTKB | Cytek Biosciences, Inc. | $722.42M | $5.65 | 0.89% |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | $719.65M | $9.86 | 2.39% |
| IKNA | Ikena Oncology, Inc. | $718.82M | $17.16 | 1152.55% |
| INNV | InnovAge Holding Corp. | $714.66M | $5.28 | 6.45% |
| VTYX | Ventyx Biosciences, Inc. | $713.23M | $9.99 | 0.05% |
| MYGN | Myriad Genetics, Inc. | $711.16M | $7.63 | 0.39% |
| KROS | Keros Therapeutics, Inc. | $708.61M | $17.48 | 0.11% |
| GYRE | Gyre Therapeutics, Inc. | $704.05M | $7.75 | 1.27% |
| PACB | Pacific Biosciences of California, Inc. | $695.90M | $2.31 | 3.56% |
| OMER | Omeros Corporation | $686.96M | $9.69 | 0.62% |
| NUTX | Nutex Health, Inc. | $685.40M | $115.11 | 2.05% |
| CRVS | Corvus Pharmaceuticals, Inc. | $684.51M | $9.17 | 1.10% |
| CSV | Carriage Services, Inc. | $681.77M | $43.30 | 0.84% |
| WSR | Whitestone REIT | $678.06M | $13.29 | 0.60% |
| RGNX | REGENXBIO Inc. | $677.79M | $13.39 | 0.98% |
| PRME | Prime Medicine, Inc. | $676.15M | $3.82 | 2.96% |
| CGEM | Cullinan Oncology, Inc. | $671.69M | $11.37 | 3.15% |
| MGTX | MeiraGTx Holdings plc | $668.07M | $8.30 | 1.22% |
| ORGO | Organogenesis Holdings Inc. | $657.40M | $5.18 | 4.43% |
| VSTM | Verastem, Inc. | $644.13M | $10.64 | 0.09% |
| AMN | AMN Healthcare Services, Inc. | $639.40M | $16.65 | 3.31% |
| OFIX | Orthofix Medical Inc. | $637.16M | $16.09 | 0.31% |
| CBLL | CeriBell, Inc. | $629.51M | $16.97 | 0.35% |
| PROK | ProKidney Corp. | $624.73M | $2.22 | 4.72% |
| AQST | Aquestive Therapeutics, Inc. | $614.71M | $6.19 | 0.48% |
| SRDX | Surmodics, Inc. | $614.51M | $42.98 | 0.35% |
| SNDA | Sonida Senior Living, Inc. | $608.15M | $32.40 | 1.70% |
| EBS | Emergent BioSolutions Inc. | $602.90M | $11.17 | 1.09% |
| FULC | Fulcrum Therapeutics, Inc. | $591.98M | $10.94 | 3.36% |
| LAB | Standard BioTools Inc. | $576.85M | $1.50 | 4.90% |
| MNPR | Monopar Therapeutics Inc. | $575.91M | $86.18 | 1.35% |
| TCMD | Tactile Systems Technology, Inc. | $574.25M | $25.71 | 0.85% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $569.38M | $3.50 | 9.33% |
| TALK | Talkspace, Inc. | $567.55M | $3.38 | 0.88% |
| RGLS | Regulus Therapeutics Inc. | $564.95M | $8.16 | 0.00% |
| UHT | Universal Health Realty Income Trust | $563.96M | $40.65 | 1.02% |
| RAPT | RAPT Therapeutics, Inc. | $558.97M | $33.80 | 1.62% |
| SAGE | Sage Therapeutics, Inc. | $544.94M | $8.68 | 0.00% |
| AVNS | Avanos Medical, Inc. | $544.88M | $11.74 | 0.84% |
| NPCE | NeuroPace, Inc. | $544.86M | $16.36 | 0.85% |
| FDMT | 4D Molecular Therapeutics, Inc. | $544.55M | $11.66 | 6.10% |
| NAGE | Niagen Bioscience Inc | $540.29M | $6.77 | 1.74% |
| ANNX | Annexon, Inc. | $538.18M | $4.50 | 4.17% |
| ZIMV | ZimVie Inc. | $535.63M | $18.99 | 0.00% |
| DSGN | Design Therapeutics, Inc. | $534.86M | $9.39 | 0.21% |
| TRNS | Transcat, Inc. | $527.22M | $56.54 | 0.57% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $519.66M | $1.43 | 0.00% |
| LYEL | Lyell Immunopharma, Inc. | $509.23M | $24.00 | 1.68% |
| ANGO | AngioDynamics, Inc. | $508.16M | $12.40 | 0.81% |
| BVS | Bioventus Inc. | $507.98M | $7.59 | 0.78% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $507.12M | $9.28 | 1.87% |